Japan Characteristics in Healthcare Logistics

Insights by Pharma.Aero

Have your say – leave a message!

Japan, a global leader in cutting-edge innovation, plays a significant role in the pharmaceutical market, with its pharmaceutical export industry set to exceed 54 billion US dollars by 2031. The podcast explores the role of international carriers like ANA and 3PL players such as Nippon Express in the Japanese life science market.
Join Frank Van Gelder (Secretary General of Pharma.Aero) and his guests

• Masahiko Takahashi, Vice President Global Marketing of ANA Cargo
• Eddy Coopmans, Senior Healthcare Manager, Nippon Express Belgium

"Sea transportation is dominant in terms of weight, accounting for almost 80%, but in terms of value, air import and export account for over 86% of import and export in Japan."

"The demand for CGT products is increasing in Japan, with the gene therapy market projected to increase 20 times larger in 15 years starting from 2020."

"We have been strengthening our logistics contribution to the healthcare industry as a priority industry, focusing on medical devices and pharmaceuticals, and aiming for global expansion and organization development in the life science field."

Discussions revolve around the importance of air transport in the pharmaceutical industry, the challenges posed by evolving healthcare products like ATMP, and the necessity for global collaboration to enhance supply chain operations. ANA's focus on CEIV Pharma certification and advancements in pharmaceutical transportation showcase its proactive approach.

Nippon Express emphasizes the significance of end-to-end visibility and the need for innovative distribution models to meet the rising demand for cell and gene therapy products.
The direct air corridor between Belgium and Japan emerges as a crucial link, facilitating swift and secure transportation of healthcare products.

Join us as we uncover the intricate ecosystem of the life science industry and the indispensable role of logistics and transportation in shaping its future.
Stay tuned for more engaging conversations on "Insights" by Pharma.Aero.